TABLE OF CONTENT

1 North American Drug Delivery Technologies Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 North American Drug Delivery Technologies Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 North American Drug Delivery Technologies Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 North American Drug Delivery Technologies Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 North American Drug Delivery Technologies Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 North American Drug Delivery Technologies Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 North American Drug Delivery Technologies Market – By Route of Administration (Market
Size – & million/billion)
8.1 Oral Drug Delivery
8.2 Pulmonary Drug Delivery
8.3 Injectable Drug Delivery
8.4 Ocular Drug Delivery
8.5 Topical Drug Delivery
8.6 Nasal Drug Delivery
8.7 Transmucosal Drug Delivery
8.8 Implantable Drug Delivery

9 North American Drug Delivery Technologies Market – By End User
9.1 Hospitals
9.2 Home Care Settings
9.3 Ambulatory Surgical Centers/Clinics
9.4 Other

10 North American Drug Delivery Technologies Market – By Geography (Market Size – &
million/billion)
10.1 Introduction
10.2 US
10.3 Canada
10.4 Mexico

11 North American Drug Delivery Technologies Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships

12 North American Drug Delivery Technologies Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Johnson & Johnson Services, Inc.
12.3 Novartis AG
12.4 F. Hoffmann-La Roche Ltd.
12.5 Glaxosmithkline PLC
12.6 3M Company
12.7 Merck & Co., Inc.
12.8 Pfizer, Inc.
12.9 Becton, Dickinson and Company
12.10 Bayer AG
12.11 Antares Pharma, Inc.
12.12 Company 11 & more

13 North American Drug Delivery Technologies Market – Appendix
13.1 Sources
13.2 Abbreviations